Reference
Alfayez M, et al. First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL). Leukemia and Lymphoma 61: 445-449, No. 2, 2020. Available from: URL: http://doi.org/10.1080/10428194.2019.1660967
Rights and permissions
About this article
Cite this article
Alemtuzumab/pentostatin/venetoclax. Reactions Weekly 1794, 17 (2020). https://doi.org/10.1007/s40278-020-75813-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-75813-6